lecture:2008 NCSF-CIHR funded International Symposium on the Role of Lipids in Cardiovascular/Metabolic Disorders and Neurological Abnormalities

   

2008 NCSF-CIHR funded International Symposium on the Role of Lipids in Cardiovascular/Metabolic Disorders and Neurological Abnormalities
Organizer: Key Laboratory of Molecular Cardiovascular Sciences,
Ministry of Education, Peking University
(脂质在代谢性血管病和神经病变中的作用国际研讨会)
组织者:教育部分子心血管学重点实验室
北京大学医学部会议中心205室,Sept. 22, 2008 Monday, Beijing
 
 
8:30.     Opening Remarks: Dr. Xian Wang or Weigang Fang, Vice President of HSC Peking University
 
Session I   
Chair:    Thomas Olivecrona, Professor and formal Dean, Department of Biochemistry, Umea University, Sweden
8:40.     The role of hepatic ABCA1 in lipoprotein metabolism
John Parks, professor, Molecular Pathology, Wake Forrest University, NC, USA
9:10       Gene Therapy for Lipoprotein Lipase Deficiency: Into the Clinic
Colin Ross, Senior Scientist, CMMT, UBC, Vancouver, Cananda
9:40       Hypertriglyceridemia and Atherosclerosis: role of oxidized Chylomicron and its remnants
George Liu, professor, Institute of Cardiovascular Sciences, HSC PKU
10:10-10:30 Coffee Break
 
Session II
Chair:    George Liu, Professor, Institute of Cardiovascular Sciences, HSC PKU
10:30     Lipoprotein lipase-a powerful enzyme with a built-in regulatory switch. Gunilla Olivecrona, Professor, Department of Biochemistry, Umea University, Sweden
11:00  Lipids as Important Players in Alzheimer Disease. Dehua Cui, Professor, Institute of Neuroscience, HSC PKU
11:30     Lunch
 
Session III
Chair:    Colin Ross, Senior Scientist,
13:30     Molecular mechanisms of SR-A-mediated foam cell formation. Qi Chen, Professor, Atherosclerosis Center, Nanjing Medical University.
14:00     Palmitoylation of ABCA1 is essential for its trafficking and function
Roshni Singaraja, Senior Scientist, CMMT, UBC, Vancouver, Cananda
14:30     Expression profiling of hepatic genes associated with lipid metabolism in nephrotic rats. Youfei Guan, Professor, Department of Physiology, HSC PKU
15:00     Activation of Transient Receptor Potential Vanilloid Type-1 Channel attenuates atherosclerosis. Professor Zhiming Zhu, Department of Endocrinology, Chongqing Medical University,
15:30-15:50 Coffee Break
 
Session IV
Chair:    John Parks, Professor, Wake Forrest University
15:50     The Canadian Pharmacogenomics Network for Drug Safety: Severe Adverse Drug Reactions in Children. Colin Ross, Senior Scientist, CMMT, UBC, Vancouver, Canada
16:20     Apolipoprotein A-I oxidation and possible role of amino acid in function loss. Professor Lemin Zheng, Department of Physiology, HSC PKU
16:50     Macrophage Cholesterol Homeostasis and Atherosclerosis. Ruud Out, Senior Scientist, Department of Pharmaceutical Sciences, Leiden University, Holland
17:20     Closing